Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02604667 · ClinicalTrials.gov registry record
Mechanisms of Ischemic Stroke in Cancer Patients
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 150
- Enrollment target
NCT02604667 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 150 participants.
The verdict
NCT02604667 has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
The purpose of this study is to better understand the causes of stroke in people with cancer. Active cancer increases the risk of stroke. The investigators do not know exactly why this occurs but one possible reason is that people with cancer may have thicker blood than people without cancer. Thick blood can sometimes cause blood clots to form in the heart, which can then travel to the brain and cause stroke. This study is being done to help figure out why this and other causes of stroke occur in people with cancer. The investigators expect that information from this study will help doctors to more effectively prevent and treat stroke in individuals with cancer.
Interventions
- OTHER Blood tests
- OTHER Transcranial Doppler Microemboli Detection Study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2016-04-08 |
| Est. Completion | 2020-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02604667
The ClinicalTrials.gov registry entry for NCT02604667 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blood tests is the first listed.
NCT02604667 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02604667 about?
NCT02604667 is a clinical study titled "Mechanisms of Ischemic Stroke in Cancer Patients". The purpose of this study is to better understand the causes of stroke in people with cancer. Active cancer increases the risk of stroke. The investigators do not know exactly why this occurs but one possible reason is that people with cancer may have thicker blood than people without cancer. Thick ...
What is the current status of trial NCT02604667?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2016-04-08. Estimated completion is 2020-09-01.
What interventions are being tested in trial NCT02604667?
The interventions under investigation include: Blood tests (OTHER), Transcranial Doppler Microemboli Detection Study (OTHER).
Who is sponsoring clinical trial NCT02604667?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.